# PHASE 3: IN VITRO OSTEOGENIC VALIDATION PROTOCOL
## Cell Culture & Molecular Analysis Procedures

**Phase Duration**: 4 months  
**Start**: Month 6 (after Phase 2 completion)  
**Key Deliverable**: Demonstration of enhanced osteogenic gene expression & mineralization in propolis-coated membranes

---

## PHASE 3 OVERVIEW

Phase 3 validates the osteogenic potential of propolis-coated collagen membranes using MC3T3-E1 pre-osteoblast cells. This phase includes cell proliferation assessment, differentiation marker analysis, and comprehensive gene expression profiling to establish the mechanistic basis for enhanced bone regeneration.

### Phase 3 Objectives
1. Culture MC3T3-E1 osteoblasts on propolis-coated membranes
2. Assess cell proliferation and viability
3. Evaluate osteogenic differentiation markers (ALP, mineralization, gene expression)
4. Compare coated vs. uncoated membrane effects
5. Identify optimal propolis concentration for in vivo testing

---

## 1. CELL CULTURE SETUP & MATERIALS

### 1.1 Cell Line Selection & Maintenance

**Cell Line**: MC3T3-E1 (Clone 14) Pre-osteoblast cells

**Characteristics:**
- Mouse calvarial cells
- Well-characterized for osteoblast differentiation studies
- Standard model for bone regeneration research
- Responsive to osteogenic stimuli
- Contact: ATCC (CRL-2593)

**Cell Culture Protocol**:

**Growth Medium (Proliferation):**
- Dulbecco's Modified Eagle's Medium (DMEM) + GlutaMAX
- 10% fetal bovine serum (FBS)
- 1% penicillin-streptomycin (P/S)
- pH 7.2-7.4
- Sterile-filter before use

**Differentiation Medium (Osteogenic):**
- DMEM + GlutaMAX
- 10% FBS
- 1% P/S
- 50 μM L-ascorbic acid 2-phosphate (vitamin C derivative)
- 10 mM β-glycerophosphate (substrate for ALP)
- 100 nM dexamethasone (corticosteroid, osteogenic inducer)
- Prepare fresh every 3-4 days

### 1.2 Cell Maintenance & Passage

**Culture Conditions:**
- Temperature: 37°C
- Atmosphere: 5% CO₂, 95% air
- Incubator: Standard tissue culture incubator
- Culture vessel: Tissue culture flasks (T25 or T75, non-coated)

**Passage Protocol:**
- Maintain cells at 70-80% confluence (not overgrown)
- Passage ratio: 1:3 to 1:5 every 2-3 days
- Trypsin detachment: 0.25% trypsin-EDTA, 2 minutes at 37°C
- Viability: ≥95% (confirmed via trypan blue)
- Maximum passages: 10-15 from stock (discard after, get fresh vial)

**Preparation for Experiment:**
- Expand cells to sufficient quantity (>10⁶ cells needed for full experiment)
- Test viability (should be ≥95%)
- Seed onto membranes 24 hours after passage (allows recovery)

### 1.3 Substrate Preparation

**Membrane Samples for Culture:**
- Cut coated membranes to 10 mm diameter discs (use sterile scissors)
- Sterilize via ethylene oxide (EtO) gas (if not pre-sterilized)
- Alternative: Sterilize with 70% ethanol (5 min), rinse in sterile PBS (3×)
- Place in sterile tissue culture wells (24-well plate format recommended)

**Controls Prepared Simultaneously:**
- **Control 1**: Uncoated collagen membranes (10 mm discs)
- **Control 2**: Tissue culture plastic (TCP) positive control
- **Control 3**: Empty wells (for osmotic effects)
- **Negative Control**: Cells in growth medium (non-osteogenic)

**Well Setup:**

| Well | Sample | Medium Type | n Replicates |
|---|---|---|---|
| **A1-A5** | P-Coat 1.0% | Growth | 5 |
| **A6-A10** | P-Coat 1.0% | Osteogenic | 5 |
| **B1-B5** | Uncoated | Growth | 5 |
| **B6-B10** | Uncoated | Osteogenic | 5 |
| **C1-C5** | TCP | Osteogenic | 5 |
| **C6-C10** | Empty | Osteogenic | 5 |

---

## 2. CELL SEEDING & CULTURE PROTOCOL

### 2.1 Cell Seeding Procedure

**Seeding Density Determination:**
- Optimal seeding: 10,000-20,000 cells per 10 mm membrane disc
- For 24-well plate: ~40,000 cells per well in 500 μL medium
- Cell suspension: Prepare in growth medium

**Step-by-Step Seeding:**

1. **Count cells**
   - Prepare single-cell suspension in growth medium
   - Count via hemocytometer or automatic cell counter
   - Viability: ≥95% (trypan blue exclusion)
   - Adjust to 100,000 cells/mL in growth medium

2. **Prepare wells**
   - Place sterilized membrane disc in bottom of each well
   - Add 500 μL pre-warmed growth medium to each well
   - Pre-incubate in incubator 20 minutes

3. **Seed cells**
   - Add 200 μL cell suspension (20,000 cells) to each well
   - Gentle pipetting to distribute evenly on membrane
   - Incubate 2 hours at 37°C (allows cell attachment)

4. **Add complete medium**
   - After 2 hours, add additional 300 μL growth medium
   - Total volume per well: 1 mL (standard for 24-well)
   - Return to incubator

5. **Culture initiation**
   - Day 0: Cells on membranes in growth medium
   - Day 1: Replace medium with either growth or osteogenic medium (as per experimental design)

### 2.2 Culture Timeline

**Duration**: 21 days (standard for osteoblast differentiation)

**Medium Changes:**
- Growth medium: Change every 2-3 days (no special factors)
- Osteogenic medium: Change every 3-4 days (reagents degrade)
- Careful removal to avoid disturbing cells on membrane (use 18G needle to aspirate)

**Culture Schedule:**

| Day | Activity | Notes |
|---|---|---|
| **0** | Cell seeding (20,000 cells/well) | Attachment phase |
| **1** | Medium replacement | Start growth vs. osteogenic |
| **3, 5, 7** | Medium changes | Remove spent, add fresh |
| **7** | Sampling Day 1 (MTT, gene expression) | First timepoint |
| **9, 11, 13** | Medium changes | Continue |
| **14** | Sampling Day 2 (ALP, gene expression) | Early differentiation |
| **15, 17, 19** | Medium changes | Final phase |
| **21** | Final Sampling Day 3 (Mineralization, gene expression) | Completion |

---

## 3. CELL VIABILITY & PROLIFERATION ASSAYS

### 3.1 MTT Assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)

**Objective**: Assess cell viability and proliferation at 3 timepoints

**Principle**: Living cells metabolize MTT (yellow) to formazan (purple), measured spectrophotometrically

**Materials:**
- MTT solution (5 mg/mL in PBS)
- Isopropanol (for formazan dissolution)
- Dimethyl sulfoxide (DMSO, alternative solvent)

**Procedure (Days 1, 7, 14, 21):**

1. **Prepare MTT reagent**
   - Dilute stock 5 mg/mL MTT in PBS to 1 mg/mL
   - Keep protected from light
   - Use within 2 hours of dilution

2. **Cell incubation with MTT**
   - Remove culture medium from wells carefully
   - Rinse wells gently with warm PBS (avoid membrane dislodgement)
   - Add 500 μL fresh growth medium (or osteogenic medium)
   - Add 50 μL MTT solution (1 mg/mL) per well
   - Final MTT concentration: ~100 μg/mL
   - Incubate 3-4 hours at 37°C (purple color develops)

3. **Formazan solubilization**
   - Remove MTT solution and medium carefully
   - Add 500 μL isopropanol per well
   - Incubate 10 minutes at room temperature
   - Mix gently to dissolve formazan crystals

4. **Measurement**
   - Transfer 200 μL solubilized formazan to 96-well microplate
   - Measure absorbance at 570 nm (reference: 690 nm)
   - Record values

**Data Analysis:**
- Calculate mean absorbance for each group (n=5)
- Normalize to Day 0 (seeding baseline = 100%)
- Plot: Relative cell viability (%) vs. Culture day

**Expected Results:**

| Day | TCP (Control) | P-Coat 1.0% | Uncoated |
|---|---|---|---|
| **0** | 100% | 100% | 100% |
| **7** | 250% | 280%* | 200% |
| **14** | 400% | 480%* | 320% |
| **21** | 500% | 600%* | 400% |

*P-Coat typically shows enhanced proliferation due to propolis bioactivity

**Pass Criterion**: ✓ Coated membrane supports ≥1.5× proliferation vs. uncoated at Day 21

### 3.2 Live/Dead Staining (Optional, for Visualization)

**Objective**: Microscopic visualization of cell health

**Method:**
- Use calcein-AM (live cells, green fluorescence) + ethidium homodimer-1 (dead cells, red)
- Incubate 30 min, image via fluorescence microscope
- Qualitative assessment of cell density and viability

---

## 4. OSTEOGENIC DIFFERENTIATION MARKERS

### 4.1 Alkaline Phosphatase (ALP) Activity Assay

**Objective**: Quantify ALP enzyme activity, early osteogenic marker

**Principle**: ALP hydrolyzes p-nitrophenyl phosphate (p-NPP) to p-nitrophenol (yellow), measured at 405 nm

**Materials:**
- ALP substrate solution (p-NPP in buffer, commercial kit)
- NaOH (to stop reaction)
- Cell lysis buffer (0.1% Triton X-100 in PBS)

**Procedure (Days 7, 14):**

1. **Cell lysis**
   - Carefully remove culture medium
   - Rinse wells with cold PBS (2×)
   - Add 300 μL lysis buffer per well
   - Incubate 15 minutes on ice
   - Pipette up/down to lyse cells completely
   - Transfer lysate to microcentrifuge tube

2. **Protein quantification**
   - Measure total protein in lysate via BCA or Bradford assay
   - Record total protein per well

3. **ALP activity assay**
   - Add 100 μL cell lysate to fresh microplate well
   - Add 100 μL ALP substrate solution
   - Incubate 30 minutes at 37°C (yellow color develops)
   - Stop reaction with 50 μL 1 M NaOH
   - Measure absorbance at 405 nm

4. **Calculation**
   - Create standard curve using ALP enzyme standard (0-100 U/mL)
   - Determine ALP activity from standard curve
   - **Normalize**: ALP activity (U) / Total protein (mg) = **Specific ALP activity (U/mg protein)**

**Expected Results:**

| Group | Day 7 | Day 14 |
|---|---|---|
| **TCP + Growth medium** | 2-3 U/mg | 3-5 U/mg |
| **TCP + Osteogenic medium** | 8-12 U/mg* | 15-25 U/mg* |
| **Uncoated + Osteogenic** | 10-15 U/mg | 18-28 U/mg |
| **P-Coat 1.0% + Osteogenic** | 15-20 U/mg* | 28-40 U/mg* |

*Higher activity indicates superior osteogenic induction

**Pass Criterion**: ✓ Coated membrane ALP activity ≥1.3× uncoated at Day 14

### 4.2 Mineralization Assay (Alizarin Red Staining)

**Objective**: Visualize and quantify calcium deposition (mineralized matrix)

**Principle**: Alizarin red dye binds calcium, producing red color proportional to mineralization

**Materials:**
- Alizarin red S solution (40 mM in ultrapure water, pH 4.2)
- Ethanol (70% and 100%)
- Cetylpyridinium chloride (CPC, for quantification)

**Procedure (Day 21):**

1. **Cell fixation**
   - Remove culture medium
   - Rinse with PBS (2×)
   - Fix with 4% paraformaldehyde in PBS, 20 minutes at room temperature
   - Rinse with distilled water (2×)
   - Air dry

2. **Alizarin red staining**
   - Add 400 μL Alizarin red S (40 mM) per well
   - Incubate 20 minutes at room temperature (dark)
   - Rinse thoroughly with ultrapure water until water runs clear
   - Air dry

3. **Quantification (optional)**
   - Add 400 μL CPC solution (0.1 M in HCl, pH 1.0)
   - Incubate 15 minutes (dye dissolves)
   - Transfer to microplate
   - Measure absorbance 562 nm

4. **Microscopy**
   - Image stained wells with light microscope
   - Red mineralized areas indicate calcium deposition
   - Photograph for comparison between groups

**Expected Observations:**

| Group | Alizarin Red Staining |
|---|---|
| **Growth medium control** | Minimal/negative (white) |
| **TCP + Osteogenic** | Moderate red staining |
| **Uncoated + Osteogenic** | Moderate-strong red staining |
| **P-Coat 1.0% + Osteogenic** | Strong red staining** |

**Pass Criterion**: ✓ Coated membrane shows ≥1.5× mineral deposition (by optical density) vs. uncoated

### 4.3 Calcium Content Determination

**Objective**: Quantify total calcium accumulated in cultures

**Principle**: Calcium in lysate chelates with o-cresolphthalein complexone, producing colored complex

**Materials:**
- Calcium assay kit (colorimetric, Sigma or equivalent)
- Cell lysis buffer
- Acid-ethanol (1 M HCl in 95% ethanol)

**Procedure (Day 21):**

1. **Cell preparation**
   - Fix cells as in Section 4.2
   - Rinse with PBS
   - Add 500 μL 1 M HCl in 95% ethanol
   - Incubate 24 hours to demineralize
   - Acidic extract now contains dissolved calcium

2. **Calcium assay**
   - Centrifuge acidic extract (1500g, 5 min)
   - Transfer 100 μL supernatant to microplate
   - Add 50 μL assay reagent
   - Incubate 5 minutes (color develops)
   - Measure absorbance 570 nm

3. **Calculation**
   - Create standard curve (0-5 mM CaCl₂)
   - Calculate calcium content (μmol/well)
   - Normalize to protein content for comparison

**Expected Results:**

| Group | Calcium Content (μmol/well) |
|---|---|
| **Growth medium control** | 0.5-1.0 |
| **TCP + Osteogenic** | 2.5-4.0 |
| **Uncoated + Osteogenic** | 3.0-5.0 |
| **P-Coat 1.0% + Osteogenic** | 5.0-8.0** |

**Pass Criterion**: ✓ Coated membrane accumulates ≥1.5× calcium vs. uncoated

---

## 5. GENE EXPRESSION ANALYSIS (qPCR - Real-Time PCR)

### 5.1 RNA Extraction

**Objective**: Isolate total RNA from cultured osteoblasts for gene expression analysis

**Materials:**
- TRIzol reagent (Invitrogen or equivalent)
- Chloroform
- Isopropanol
- 75% ethanol
- RNase-free water

**Protocol (Days 7, 14, 21):**

1. **Cell lysis**
   - Remove culture medium
   - Rinse wells with cold PBS
   - Add 500 μL TRIzol per well
   - Incubate 5 minutes at room temperature
   - Pipette to ensure complete cell lysis

2. **Phase separation**
   - Transfer TRIzol lysate to microcentrifuge tube
   - Add 100 μL chloroform (1/5 volume of TRIzol)
   - Vortex 15 seconds
   - Incubate 2-3 minutes at room temperature
   - Centrifuge 12,000g, 4°C, 15 minutes

3. **Aqueous phase recovery**
   - Transfer upper aqueous phase to fresh tube (contains RNA)
   - Avoid white interphase (proteins)

4. **RNA precipitation**
   - Add equal volume of isopropanol
   - Incubate 10 minutes at room temperature
   - Centrifuge 12,000g, 4°C, 10 minutes
   - Discard supernatant

5. **RNA washing**
   - Resuspend pellet in 75% ethanol
   - Centrifuge 7,500g, 4°C, 5 minutes
   - Discard ethanol
   - Air dry pellet (~5 minutes, do not over-dry)

6. **RNA dissolution**
   - Add 20-50 μL RNase-free water
   - Incubate 15 minutes at 4°C to dissolve
   - Store at -20°C (short-term) or -80°C (long-term)

### 5.2 RNA Quality Assessment

**Agarose Gel Electrophoresis:**
- Run 1 μL RNA on 1% agarose gel
- Expected: Two sharp bands (28S and 18S ribosomal RNA)
- Integrity: 28S:18S band intensity ratio ~2:1 (indicates good quality)

**Spectrophotometry:**
- Measure absorbance at 260 nm and 280 nm
- RNA concentration: A₂₆₀ × dilution factor × 40 (μg/mL)
- Purity ratio A₂₆₀/A₂₈₀: Should be 1.8-2.0
- If <1.8, suggests protein contamination; re-extract

**Pass criterion**: ✓ RNA with A₂₆₀/A₂₈₀ > 1.8 and clear ribosomal bands

### 5.3 cDNA Synthesis (Reverse Transcription)

**Objective**: Convert mRNA to complementary DNA (cDNA) for qPCR amplification

**Materials:**
- SuperScript III Reverse Transcriptase (or equivalent)
- Oligo(dT)₂₀ primers (or random hexamers)
- 10 mM dNTPs mix
- 5× RT buffer

**Protocol:**

1. **Reaction setup (per sample, 20 μL total)**
   - 0.5 μg total RNA
   - 0.5 μL oligo(dT)₂₀ (0.5 μg)
   - 0.5 μL 10 mM dNTPs
   - 4 μL 5× RT buffer
   - 1 μL SuperScript III
   - RNase-free water to 20 μL

2. **Incubation**
   - 25°C, 5 minutes (primer annealing)
   - 50°C, 60 minutes (cDNA synthesis)
   - 70°C, 15 minutes (enzyme inactivation)
   - Store at -20°C or use immediately

### 5.4 Real-Time Quantitative PCR (qPCR)

**Objective**: Quantify mRNA abundance of osteogenic genes

**Genes to Measure:**

| Gene | Abbreviation | Function | Peak Expression Day |
|---|---|---|---|
| **Runt-related transcription factor 2** | RUNX2 | Early osteoblast differentiation | 7-14 |
| **Osteocalcin** | OCN / BGLAP | Mineralization, late differentiation | 14-21 |
| **Alkaline phosphatase** | ALP / ALPL | Matrix maturation | 7-14 |
| **Type I Collagen** | COL1A1 | Bone matrix protein | 7-21 |
| **Osterix** | SP7 | Osteoblast-specific transcription factor | 7-14 |
| **Osteopontin** | OPN / SPP1 | Bone matrix protein | 14-21 |

**Reference Genes (Housekeeping):**
- GAPDH (Glyceraldehyde 3-phosphate dehydrogenase)
- ACTB (β-actin)
- 18S rRNA

**Primer Design/Selection:**

All primers should be:
- Validated mouse primers (published or from qPCR primer databases)
- Span introns (to detect mRNA, not genomic DNA)
- GC content 40-60%
- Product length 80-150 bp

**Example Primer Set:**

| Gene | Forward Primer (5'→3') | Reverse Primer (5'→3') |
|---|---|---|
| **RUNX2** | TGGTTACTGTCATGGCGGGTA | TCTCAGATCGTTGAACCTTGCTA |
| **OCN** | CACTCCTCGCCCTATTGGC | CCCTCCTGCTTGGACACAAAG |
| **GAPDH** | TGTGTCCGTCGTGGATCTGA | CCTGCTTCACCACCTTCTTGA |

*Obtain primers from validated sources (Thermo Fisher, IDT, Sigma)*

**qPCR Protocol:**

**Reaction Setup (per sample, 20 μL):**
- 10 μL 2× SYBR Green Master Mix
- 0.5 μL Forward primer (10 μM)
- 0.5 μL Reverse primer (10 μM)
- 2 μL cDNA (diluted 1:5 in water)
- 7 μL RNase-free water

**Cycling Parameters:**
- Initial denaturation: 95°C, 10 minutes
- 40 cycles of:
  - Denaturation: 95°C, 15 seconds
  - Annealing/Extension: 60°C, 60 seconds (collect fluorescence)
- Melt curve: 95°C 15 sec → 60°C 60 sec (ramp to 95°C)

**Data Analysis:**

1. **Cq (Cycle quantification) determination**
   - Software automatically determines Cq (cycle at threshold)
   - Cq = cycle number when fluorescence exceeds background
   - Lower Cq = more starting template (higher expression)

2. **Relative quantification (ΔΔCq method)**
   - **ΔCq = Cq(target gene) - Cq(reference gene)**
   - **ΔΔCq = ΔCq(experimental group) - ΔCq(control group)**
   - **Relative expression = 2^(-ΔΔCq)**

3. **Example Calculation**
   - RUNX2 in coated membrane (osteogenic) vs. uncoated membrane (osteogenic)
   - RUNX2 Cq (coated) = 18, GAPDH Cq (coated) = 12 → ΔCq = 6
   - RUNX2 Cq (uncoated) = 20, GAPDH Cq (uncoated) = 12 → ΔCq = 8
   - ΔΔCq = 6 - 8 = -2
   - Relative expression = 2^(-(-2)) = 2^2 = **4-fold higher in coated**

### 5.5 Expected Gene Expression Results

**Day 7 (Early Differentiation):**

| Gene | Growth Medium | Uncoated | P-Coat 1.0% |
|---|---|---|---|
| **RUNX2** | 1.0 (baseline) | 3-4× | 5-7×* |
| **ALP** | 1.0 | 2-3× | 4-5×* |
| **Osterix** | 1.0 | 2-3× | 4-5×* |

**Day 14 (Mid-Differentiation):**

| Gene | Growth Medium | Uncoated | P-Coat 1.0% |
|---|---|---|---|
| **RUNX2** | 1.0 | 3-4× | 5-8×* |
| **OCN** | 1.0 | 5-7× | 10-15×* |
| **Collagen I** | 1.0 | 4-6× | 8-12×* |
| **OPN** | 1.0 | 4-5× | 6-10×* |

**Day 21 (Late Mineralization):**

| Gene | Growth Medium | Uncoated | P-Coat 1.0% |
|---|---|---|---|
| **OCN** | 1.0 | 8-12× | 15-25×* |
| **Collagen I** | 1.0 | 6-10× | 12-20×* |

*Enhanced expression indicates superior osteogenic induction by propolis coating

**Pass Criterion**: ✓ Coated membrane shows ≥2-fold higher expression of RUNX2, OCN, Collagen I, Osterix vs. uncoated at corresponding timepoints

---

## 6. DATA COMPILATION & ANALYSIS

### 6.1 Summary Data Table

Create comprehensive table consolidating all Phase 3 results:

| Parameter | Unit | Growth Ctrl | Uncoated | P-Coat 1.0% |
|---|---|---|---|---|
| **MTT Day 21** | % of Day 0 | 400% | 500% | 600%* |
| **ALP Day 14** | U/mg protein | 5 | 20 | 32* |
| **Calcium Day 21** | μmol/well | 1.0 | 4.5 | 7.0* |
| **RUNX2 Day 14** | Fold change | 1 | 4× | 7×* |
| **OCN Day 14** | Fold change | 1 | 7× | 13×* |
| **COL1A1 Day 14** | Fold change | 1 | 5× | 10×* |

### 6.2 Statistical Analysis

**Methods:**
- One-way ANOVA (comparing ≥3 groups)
- Post-hoc test: Tukey HSD (if ANOVA p<0.05)
- Significance level: p<0.05
- Report as: Mean ± SD (n=5)

**Expected Outcome**: Coated membrane significantly different from uncoated (p<0.05) for ≥80% of markers

### 6.3 Visualization

Create graphs for:
- MTT proliferation curves (line graph, days 0-21)
- ALP activity comparison (bar graph, Day 14)
- Calcium deposition comparison (bar graph, Day 21)
- Gene expression heatmap (RUNX2, OCN, COL1A1, Osterix across days 7, 14, 21)
- qPCR fold-change bar graphs for each gene

---

## 7. ANTIMICROBIAL SUPPLEMENTARY TESTING

### 7.1 Bacterial Challenge Test (Optional)

**Objective**: Confirm propolis antimicrobial activity during cell culture

**Method:**
- Culture propolis-coated membrane + MC3T3-E1 cells for 3 days
- Co-culture with *Staphylococcus aureus* (10⁵ CFU/mL) for 24 hours
- Enumerate surviving bacteria (CFU count)
- Compare survival on coated vs. uncoated membranes

**Expected Result**: ≥3-log reduction in bacterial CFU on propolis-coated vs. uncoated membrane

---

## 8. PHASE 3 DELIVERABLES

### 8.1 Documentation Required

- [ ] **Cell Culture Protocol SOP** (detailed step-by-step procedures)
- [ ] **MTT Assay Data** (absorbance values, normalized results)
- [ ] **ALP Activity Results** (specific activity calculations)
- [ ] **Mineralization Data** (alizarin red quantification & calcium assay)
- [ ] **qPCR Results** (Cq values, ΔΔCq calculations, fold-change data)
- [ ] **Statistical Analysis Report** (ANOVA results, p-values)
- [ ] **Gene Expression Summary Table** (consolidated results all genes/timepoints)
- [ ] **Graphs & Figures** (all visualizations, publication-ready)

### 8.2 Success Metrics (≥80% Must Be Met)

✓ Cell viability on coated membrane ≥400% of baseline at Day 21  
✓ ALP activity on coated ≥1.3× uncoated at Day 14  
✓ Mineralization (calcium) ≥1.5× uncoated at Day 21  
✓ RUNX2 expression ≥2× higher in coated vs. uncoated (Days 7,14)  
✓ OCN expression ≥2× higher in coated vs. uncoated (Days 14,21)  
✓ Collagen I expression ≥2× higher in coated vs. uncoated (Days 7,14,21)  
✓ Statistical significance p<0.05 for major markers (RUNX2, OCN, ALP, calcium)  
✓ Consistent results across all replicates (n=5 per group)  
✓ Complete gene expression profile spanning 3 timepoints

---

## 9. TIMELINE & RESOURCE ALLOCATION

| Week | Activity | Personnel | Equipment |
|---|---|---|---|
| 1-2 | Cell expansion & membrane prep | Technician | Incubator, biosafety cabinet |
| 3 | Cell seeding onto membranes | Technician | Biosafety cabinet |
| 3-9 | Medium changes 2-3×/week | Technician | Incubator |
| 7 | Day 1 sampling (MTT, RNA extraction) | Technician | Centrifuge, spectrophotometer |
| 14 | Day 2 sampling (ALP, MTT, RNA) | Technician | Incubator, plate reader |
| 21 | Day 3 sampling (ALP, Mineralization, RNA) | Technician | Incubator, imaging |
| 8-16 | qPCR analysis (3 timepoints) | Molecular biologist | qPCR system |
| 16-17 | Data analysis & statistics | Scientist | Computer, statistics software |

**Total Duration**: 17 weeks (~4 months, with overlapping activities)

---

## 10. TROUBLESHOOTING GUIDE

| Issue | Cause | Solution |
|---|---|---|
| **Low cell attachment on membrane** | Poor hydrophilicity | Pre-coat membrane with fibronectin (10 μg/mL, overnight) |
| **Cell detachment during medium change** | Mechanical disruption | Use very slow pipetting, angled needle for aspiration |
| **High background in qPCR** | Genomic DNA contamination | Treat RNA with DNase before cDNA synthesis |
| **Variable MTT results** | Inconsistent incubation time | Use strict timing, prepare MTT fresh |
| **Low ALP activity** | Insufficient osteogenic induction | Increase dexamethasone to 100 nM or β-glycerophosphate to 20 mM |
| **RNA degradation** | RNase contamination | Use RNase-free water, tips, tubes; keep on ice |
| **No mineralization** | Culture too short | Extend to Day 25-28 if needed |

---

## CONCLUSION

Phase 3 comprehensively validates the **osteogenic potential of propolis-coated collagen membranes** through:

1. **Enhanced cell proliferation** (MTT assay)
2. **Increased differentiation markers** (ALP, calcium deposition)
3. **Superior gene expression** (RUNX2, OCN, osteogenic genes ≥2×)
4. **Sustained bioactivity** throughout 21-day culture

These results establish the **scientific basis for in vivo GBR study** and identify optimal propolis concentration for Phase 4.

---

**Document Status**: ✓ Complete Phase 3 Protocol  
**Next Steps**: Proceed to Phase 4 - In Vivo GBR Efficacy Study (phase-4-invivo-protocol.md)
